Semaglutide's role extends beyond diabetes, aiding weight loss and offering cardiovascular protection, with ongoing research ...

They also don’t directly support behavior change, which Kathryn Ilonka Pollak, PhD, a professor in population health sciences ...

Eli Lilly has invested heavily into obesity, dominating the landscape—alongside semaglutide maker Novo Nordisk—with its ...

The diet, which is rich in fats and low in carbohydrates, may help alter how your body manages and utilises energy, ...

Analyst Samantha Semenkow from Citi maintained a Hold rating on BioAge Labs, Inc. (BIOA – Research Report) and keeping the price target at ...

BioAge Labs, Inc. (BIOA – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst yesterday. Analyst Jeffrey ...

Operator Ladies and gentlemen, thank you for standing by and welcome to the Lilly Q4 2024 earnings call. [Operator ...

Life Sciences Ontario (LSO) proudly announces the recipients of the 2025 LSO Awards, celebrating excellence and innovation in life sciences. Now in its 22nd year, the LSO Awards continues its ...

CCK denotes cholecystokinin, GI gastrointestinal, GLP-1 glucagon-like peptide 1 ... physical exercise, reproductive biology, bone metabolism, and feeding behavior. Paradoxically, ghrelin levels ...

Boosting Bacteroides vulgatus in diabetic mice increased GLP-1 secretion, improving blood sugar control and reducing sugar cravings.

“The 12 per cent reduction we found may seem like a weak effect but it is teaching us about the biology of Alzheimer ... enhancement of the activity of glucagon-like peptide 1, a hormone ...